EMEA-001114-PIP01-10-M03

Key facts

Invented name
Elocta
Active substance
Efmorocotocog alfa
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0149/2016
PIP number
EMEA-001114-PIP01-10-M03
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of hereditary factor-VIII deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Biogen Idec Ltd
United Kingdom
Tel. +44 (0) 16285 12609 / 44 (0)7557057823
Fax +44 (0) 16285 12696
E-mail: amit.patel@biogen.cpm
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating